drugset
Drugs / TB/Flu-05E
last change Apr 2024 re-read 3 minutes ago

TB/Flu-05E

also known as ТВ/Flu-05Е

Vaccine

Developed for
tuberculosis
Investigated by
Pavlov First Saint Petersburg State Medical University · Research Institute of Influenza, Russia · St. Petersburg City Polyclinic No. 34

Trials 1

today NCT06873282 · Ph 2
202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06873282 Dec 2023 → Jan 2024 tuberculosis Research Institute of Influenza, Russia Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TB/Flu-05E ClinicalTrials.gov intervention name — accepted as the source's own label NCT06873282 ↗
Known as ТВ/Flu-05Е “Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine” NCT06873282 ↗
Modality Vaccine “TB/Flu-05E vaccine” NCT06873282 ↗
Route Intranasal “single intranasal injection of TB/Flu-05E vaccine” NCT06873282 ↗